In the UK, several GLP-1 receptor agonists are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA), each with specific indications: semaglutide (Ozempic for type 2 diabetes, Wegovy for weight management), dulaglutide (Trulicity for type 2 diabetes), and liraglutide (Victoza for type 2 diabetes, Saxenda for weight management)
BPC-157 for tendon injuries covers the musculoskeletal animal data in detail
"Many people who take these medications have struggled their entire lives with weight and these athletes rarely have." There's also the misconception of potential enhanced performance, a claim Ortiz-Pujols debunks with the reminder that these athletes "have access to personal trainers and personal chefs with hours to train."
Methods: In this preliminary, hypothesis-generating, prospective, double-blind, cross-over study, 16 patients with glaucoma or ocular hypertension and coexisting dry eye symptoms were randomized to receive either HA alone or HA + GSH-C4 for 4 weeks, separated by a 1-week washout